Sound Sleep LLC provides a free sleep screening and consultation to the first 50 callers, offering an oral appliance therapy ...

To prepare for the new facility’s opening, VNA is supporting decarbonization strategies in carbon-intensive industries.

Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often ...

An experimental first-in-class oral selective partial D1/D5 dopamine receptor agonist for Parkinson's significantly reduce disease burden in two phase 3 trials.

Last year, they published the paper, “Genetic Study of Elf5 and Ehf in the Mouse Salivary Gland,” that was featured on the cover of the March 2023 issue of the Journal of Dental Research (JDR) and ...

Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...

Seres Therapeutics (NASDAQ:MCRB) rose 5% amid a report that Nestle (OTCPK:NSRGY) has raised its offer for the company. Nestle ...

New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex ...

Arthritis is a prevalent joint disease that impacts millions globally, causing pain, stiffness, and swelling in the affected joints. These symptoms can significantly diminish the quality of life.

(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...

PurDentix offers a 180-day, 100% money-back guarantee, providing ample time to evaluate its benefits. If you are not ...